STE vs ZURA · P/E 25, rev $5.94B vs $343.5M cap
STERIS plc (STE) versus Zura Bio Limited Class A Ordinary Shares (ZURA) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
Zura Bio Limited Class A Ordinary Shares (ZURA) is a biotechnology company listed on NASDAQ.
Latest reported STE revenue for 2026-03-31 was $5.94B. Net income was $782.3M. Revenue was up 8.7% from 2025-03-31 to 2026-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
ZURA does not have a complete income-statement cache yet.
STE currently screens at market cap $19.43B and trailing P/E 25.1. ZURA currently screens at market cap $343.5M.
Not investment advice. Open the STE and ZURA stock pages for the full models.
Not investment advice.